OP

Optigenex IncOOTC OPGX Stock Report

Last reporting period 30 Jun, 2008

Updated 02 Aug, 2023

Last price

Market cap $B

0

Micro

Exchange

OOTC - OTC

OPGX Stock Analysis

OP

Uncovered

Optigenex Inc is uncovered by Eyestock quantitative analysis.

Market cap $B

0

Dividend yield

Shares outstanding

0.41 B

Optigenex, Inc. is engaged in the manufacturing and licensing of beauty, dietary supplements, and personal care products. The company is headquartered in Scottsdale, Arizona. The company went IPO on 2005-04-15. The firm is focused on providing solutions for healthy age management. The firm is a provider of dietary supplements, skin care products and bulk ingredients. The firm formulates, licenses and markets its own natural cellular deoxyribonucleic acid (DNA) care ingredient known as ac-11. Its ac-11 is used in both dietary supplements and advanced cosmetics to repair skin damaged by overexposure to the sun, restore optimal cellular function, and promote healthy aging. The Company’s technology helps the body’s natural ability to repair DNA; enhances the immune system by increasing the life cycle of white blood cells; repairs neural function damaged by overexposure to high decibel noise; helps to normalize the expression of NF-KB, thereby regulating the cellular response to systemic inflammation, and maintains telomere length and integrity during the process of cellular mitosis.

View Section: Eyestock Rating